Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 30, 2021
Altasciences announced the continued expansion of their formulation, manufacturing, and analytical services facilities in Philadelphia, PA. Altasciences, an integrated drug development solution company offering pharmaceutical and biotechnology ...
read more
Saturday, September 25, 2021
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing and BIOVECTRA, a CDMO specializing in clinical-to-commercial scale production of high-quality regulated Biologics, Active Pharmaceutical Ingredients, and...
read more
Saturday, September 25, 2021
Clinical logistics and life science manufacturing leaders Boston Labs and Germfree Laboratories Inc. today announced their partnership to launch a new network of mobile CGT manufacturing facilities. The two companies are combining deep logistics, CGT...
read more
Saturday, September 25, 2021
Allarity Therapeutics A/S, a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers, and Lonza, a CDMO partner to the biopharma industry, announced an ...
read more
Saturday, September 25, 2021
Quell Therapeutics, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced it has entered a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult). The ...
read more
Saturday, September 25, 2021
Clean Cells, part of the Clean Biologics group, a provider of biopharmaceutical product quality control services and manufacturer of starting materials, announced an investment of €13M ($15.3M) for a new production facility in Montaigu-Vendée. By ...
read more
Friday, September 24, 2021
At Pfizer CentreOne we aspire to be the CDMO partner of choice. Over the last several years our team has been working to expand our development services offerings so we can truly be an end-to-end CDMO, from development through to commercial ...
read more
Wednesday, September 22, 2021
PMI Global Services Inc announced that its offer for Vectura Group plc has become unconditional, having received valid acceptances for or acquired 74.77 % of Vectura shares, in excess of the 50% required under the acceptance condition, as well as ...
read more
Wednesday, September 22, 2021
IBX, a global leader in biobanking, bioprocessing and analytics, has acquired UK based biospecimen storage specialists Roylance Pharma.
read more
Wednesday, September 22, 2021
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), to ...
read more
Wednesday, September 22, 2021
Seqens CDMO, a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs) and other specialty chemical products, announced that Bob Huang has joined as Managing Director for North America. The company is a ...
read more
Tuesday, September 21, 2021
Asymchem announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.
read more
Monday, September 20, 2021
Astrea Bioseparations, a leading provider of bioseparations products and services, announced two new investments to enhance operations and customer support resources. The investments include an expansion of the company’s research and development ...
read more
Tuesday, September 14, 2021
Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of viral vaccines BSL2/BSL3, oncolytic viruses and viral vectors, announces the next phase in its partnership with FluGen, Inc., a clinical-stage vaccine company ...
read more
Wednesday, September 08, 2021
National Resilience, a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem, and Moderna announced an agreement to manufacture drug substance for the Moderna COVID-19 vaccine.
read more